KIR2DL3 and common variable immunodeficiency: One previous study has also suggested that the CVID risk is increased in patients where Killer cell immunoglobulin-like receptors (KIR)/MHC class I combinations facilitate NK cell activation (B*44-KIR3DS1 and C*16-KIR2DL3) (46).